RedXL | 33.38mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 33.38 mg

7-Hydroxymitragynine: 99.49% (33.21mg)

Mitragynine Pseudoindoxyl: 0.51% (0.17mg)

Packaging Information

Packaging: Red mylar

Single Pack: 5 tablets per pack

Multipack: 50 tablets per pack

Product Description

Red XL represents the core of the 7OHBLACK lineup—a high-strength tablet formulation built with precision, transparency, and long-term performance in mind. Designed for users who value consistency and integrity, Red XL delivers a potent yet balanced alkaloid profile with every tablet.

The formulation is centered around a high concentration of 7-Hydroxymitragynine to support strong physical relief and relaxation, while a measured amount of Mitragynine Pseudoindoxyl adds balance and structure to the experience. This careful pairing promotes a smooth onset, sustained effectiveness, and reliable control without unnecessary excess.

Red XL is a Thai Style tab that is engineered for durability and repeatability, offering a steady, dependable option for users managing ongoing discomfort or demanding routines. Its profile prioritizes clarity, strength, and longevity—making it a foundational choice for those who expect their product to perform exactly as labeled.

Caution & Responsible Use

This is a high-potency product intended for experienced users. Due to its elevated alkaloid content, users should start with a low amount and allow sufficient time to fully assess individual response before considering additional use. Avoid stacking doses, and always prioritize responsible, measured consumption to ensure a safe and controlled experience.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.